Validation of PAGE-B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir.

Mi Na KimSeong Gyu HwangKyu Sung RimBeom Kyung KimJun Yong ParkDo Young KimSang Hoon AhnKwang-Hyub HanSeung-Up Kim

Published in: Liver international : official journal of the International Association for the Study of the Liver (2017)

Our study demonstrated that PAGE-B is applicable to Asian chronic hepatitis B patients receiving ETV or TDF therapy. The PAGE-B showed similar predictive performance to GAG-HCC and CU-HCC.

Keyphrases

hepatitis b virus
acute lymphoblastic leukemia
liver fibrosis
stem cells
antiretroviral therapy
smoking cessation
replacement therapy